To include your compound in the COVID-19 Resource Center, submit it here.

Fampyra dalfampridine regulatory update

EMA's CHMP reversed a prior decision and recommended conditional approval of Fampyra dalfampridine from Biogen Idec to improve walking ability

Read the full 205 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE